Sildenafil in Infants and Children
Pulmonary arterial hypertension (PAH) management has been transformed in recent times with the advent of cheap and effective diagnostic tools and therapy. Sildenafil, a phosphodiesterase-V inhibitor, has been at the centre of this treatment, and its success in treating PAH has led to its widespread...
Main Authors: | Larisa Simonca, Robert Tulloh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-07-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/4/7/60 |
Similar Items
-
Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension
by: Anne M Keogh, et al.
Published: (2008-10-01) -
The first Russian experience of sildenafil application in patients with idiopathic pulmonary hypertension
by: Z Kh Dadacheva, et al.
Published: (2015-09-01) -
One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease
by: A.C. Barreto, et al.
Published: (2005-02-01) -
Clinical case: combination therapy with iloprost and sildenafil in the treatment of idiopathic pulmonary hypertension
by: I N Zavyrylina, et al.
Published: (2015-06-01) -
Prolonged priapism following single dose administration of sildenafil: A rare case report
by: Sharma Sachit, et al.
Published: (2009-01-01)